Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
24 Oct
2023
Cognito Therapeutics Presents Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety, Adherence and Durability of Treatment Benefits Over 18 Months
News Articles
18 Oct
2023
Cognito Therapeutics to Present Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety and Durability of Treatment Benefits Over 18 Months at CTAD 2023
News Articles
17 Jul
2023
Cognito Therapeutics Presents New MRI Data Showing Non-Invasive Gamma Stimulation Therapy Reduces Brain Atrophy and Myelin Loss in Alzheimer’s Disease
News Articles
No results found.
There are no results with this criteria. Try changing your search.